WHO, WTO, WIPO Heads Call For More Medical Innovation 08/07/2013 by Brittany Ngo for Intellectual Property Watch 3 Comments The leaders of three top international organisations in Geneva last week discussed synergies in public health and called for increased collaboration and creativity to move medical innovation out of its quagmire of inefficiency. The opening session was marked by the head of the World Health Organization urging stakeholders to develop mechanisms to separate drug prices from costs of research and development. And the head of the GAVI Alliance, in the keynote address, discussed how patent thickets could impede access to vaccines.
ECOSOC Panel: Science, Technology, Innovation Essential For Universal Health Coverage 04/07/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment A United Nations Economic and Social Council (ECOSOC) panel discussion on universal health coverage (UHC) on 3 July highlighted the importance of science, technology and innovation for achieving UHC, especially in the context of the post-2015 development agenda. Speakers discussed the meaning and scope of UHC as well as the financing and promotion of UHC in various country contexts.
Equal Innovation Seen As Critical To Economic Growth, Achievement Of UN MDGs 02/07/2013 by Brittany Ngo for Intellectual Property Watch and Caitlin McGivern for Intellectual Property Watch Leave a Comment Slow and uneven economic growth was the main concern echoed by panellists participating in this morning’s high-level policy dialogue at the 2013 United Nations Economic and Social Council (ECOSOC) Substantive Session. Representatives from various intergovernmental agencies shared their perspectives on the status of the global economy with respect to innovation and the 2015 Millennium Development Goals (MDGs).
MSF: Prices On Latest ARV Drugs Under Patent Too High 02/07/2013 by Intellectual Property Watch Leave a Comment The price of first- and second-line anti-retrovirals (ARVs) have declined due to increased generic competition, while third-line regimens remain “exorbitantly priced,” according to the latest edition of a publication from Médecins Sans Frontières (MSF).
Global Innovation Index: Most Innovative Keep Top Spots 01/07/2013 by Brittany Ngo for Intellectual Property Watch and Caitlin McGivern for Intellectual Property Watch Leave a Comment Innovation is a main focus of the United Nations Economic and Social Council (ECOSOC) substantive session taking place in Geneva this week. Today, at the ECOSOC opening session, the 2013 Global Innovation Index (GII) was launched, which ranked Switzerland, Sweden, the United Kingdom, the Netherlands, and the United States as the top five most innovative countries in the world.
WHO Issues Guidelines To Push HIV Epidemic Into “Irreversible Decline” 30/06/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment The World Health Organization (WHO) has issued new recommendations that call for earlier HIV treatment with antiretroviral therapy (ART) in an effort to keep HIV patients healthier for a longer period of time.
Medicines Patent Pool Signs New Licence Agreements 26/06/2013 by Intellectual Property Watch 1 Comment The Medicines Patent Pool, Shilpa Medicare, and Gilead Sciences have signed an agreement to increase access to HIV treatment medicines. The agreement will allow Shilpa Medicare to manufacture “five key HIV medicines for sale in 100-112 countries,” and the goal is to cover “a majority of people living with HIV.”
UNAIDS Reports Sharp Drop In New HIV Infections In Some African Countries 26/06/2013 by Intellectual Property Watch Leave a Comment Since 2009, seven countries in sub-Saharan Africa have reduced new HIV infections among children by 50 percent, and others have made significant progress, according to a new report by UNAIDS. But efforts in some countries have stalled, it said.
WHO Wrestles With Engagement Of “Non-State Actors” 25/06/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment The World Health Organization is undergoing major reform including working to stabilise its fiscal future, and members are trying to set out careful terms for working with and receiving support from entities referred to as non-state actors, such as private foundations and organisations.
US Gives Boost To Materials Genome Initiative 24/06/2013 by Intellectual Property Watch Leave a Comment The Obama administration and academic and industry partners today announced their commitment to support the Materials Genome Initiative (MGI), a public-private endeavor whose aim is to reduce the time required to develop novel materials that can “fuel advanced manufacturing and bolster the 21st century American economy.”